임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

60건 표시 (상위 60건)

1상완료· Healthy Male Subjects
A Study to Compare the Auto-injector and Pre-filled Syringe of CT-P52 in Healthy Male Subjects
리드: 셀트리온
상세 →NCT07367958
1상완료· Healthy
A Bioequivalence Study of CT-L02 Compared to Co-administration (CTL0201 and CTL0202) in Healthy Volunteers
리드: 셀트리온
상세 →NCT07128654
1상완료· Type 2 Diabetes Mellitus (T2DM)
Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration of CT-L03 in Healthy Volunteers
리드: 셀트리온
상세 →NCT07158346
1상완료· Healthy Male Subjects
A Study to Compare the Auto-injector and Pre-filled Syringe of CT-P43 in Healthy Male Subjects
리드: 셀트리온
상세 →NCT06951828
1상완료· Healthy
To Compare the Pharmacokinetics, Safety, and Immunogenicity of Subcutaneous CT-P6 and Herceptin in Healthy Male Subjects (Trastuzumab)
리드: 셀트리온
상세 →NCT06687928
3상완료· Moderately to Severely Active Rheumatoid Arthritis
A Phase 3 Study to Evaluate Efficacy & Safety of Subcutaneous CT-P13 in Patients With Moderate to Severe Active Rheumatoid Arthritis
리드: 셀트리온
상세 →NCT06738719
3상완료· T2DM
Efficacy and Safety of Pioglitazone Combination Therapy in Type 2 Diabetes Patients on a Background of Empagliflozin With Metformin
리드: 셀트리온
상세 →NCT06571591
1상완료· Healthy Male Subjects
To Compare the Pharmacokinetics, Safety and Immunogenicity of CT-P55 and Cosentyx in Healthy Subjects
리드: 셀트리온
상세 →NCT07054970
1상완료· Essential Hypertension
A Bioequivalence Study of L04TD3 Compared to Administration of L04RD1 in Healthy Volunteers
리드: 셀트리온
상세 →NCT05993806
3상완료· Moderate to Severe Chronic Plaque Psoriasis
To Compare Pharmacokinetics, Efficacy, and Safety of CT-P17 With Humira in Patients With Moderate to Severe Chronic Plaque Psoriasis
리드: 셀트리온
상세 →NCT05495568
1상완료· Healthy
A Bioequivalence Study of L04TD2 Compared to Administration of L04RD1 in Healthy Volunteers
리드: 셀트리온
상세 →NCT05581693
3상완료· Rheumatoid Arthritis
A Study to Compare Efficacy and Safety of CT-P47 and RoActemra in Patients With Rheumatoid Arthritis
리드: 셀트리온
상세 →NCT05489224
1상완료· Healthy
A Bioequivalence Study of L04TD1 Compared to Administration of L04RD1 in Healthy Volunteers
리드: 셀트리온
상세 →NCT05568121
3상완료· Hypertension
Efficacy and Safety of Ezetimibe/Rosuvastatin and Amlodipine Patients With High Blood Pressure and High Cholesterol
리드: 셀트리온
상세 →NCT07564726
1상완료· Healthy
A Food Effect Study of CT-L01 After Oral Administration in Healthy Volunteers
리드: 셀트리온
상세 →NCT05364164
3상완료· Essential Hypertension
Study to Evaluate and Compare the Efficacy and Safety of AZM and AML Combined and Alone in Mild-to-moderate Essential Hypertensive Subjects
리드: 셀트리온
상세 →NCT05385770
1상완료· Healthy
A Bioequivalence Study of CT-L01 Compared to Co-administration (ALO 12.5 mg and MET XR 500 mg) in Healthy Volunteers
리드: 셀트리온
상세 →NCT05363592
1상완료· Healthy
A Bioequivalence Study of CT-L01 Compared to Co-administration (ALO 25 mg and MET XR 1,000 mg) in Healthy Volunteers
리드: 셀트리온
상세 →NCT05363384
1상완료· SARS-CoV-2 Infection
To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P63 in Healthy Subjects
리드: 셀트리온
상세 →NCT05017168
1상완료· Healthy Subject
Phase I Study to Compare the Pharmacokinetics, Pharmacodynamics, and Safety Between CT-P41 and US-licensed Prolia in Healthy Male Subjects
리드: 셀트리온
상세 →NCT06037395
1상완료· Health, Subjective
A Drug-Drug Interaction Study of CTL0801 and CTL0802 Compared to Coadministration in Healthy Adult Volunteers
리드: 셀트리온
상세 →NCT05002244
1상완료· Health, Subjective
A Drug-Drug Interaction Study of CTL0901 and CTL0902 Compared to Coadministration in Healthy Adult Volunteers
리드: 셀트리온
상세 →NCT05009368
3상완료· Diabetic Macular Edema (DME)
Study to Compare Efficacy and Safety of CT-P42 in Comparison With Eylea in Patients With Diabetic Macular Edema
리드: 셀트리온
상세 →NCT04739306
2상완료· COVID-19
Infliximab in the Treatment of Patients With Severe COVID-19 Disease
협력: 셀트리온
상세 →NCT04922827
3상완료· Postmenopausal Women With Osteoporosis
A Phase 3 Study to Compare Between CT-P41 and US-licensed Prolia in Postmenopausal Women With Osteoporosis
리드: 셀트리온
상세 →NCT04757376
3상완료· Psoriasis
A Study to Compare the Efficacy and Safety of CT-P43 to Stelara in Patients With Plaque Psoriasis
리드: 셀트리온
상세 →NCT04673786
3상완료· Chronic Spontaneous Urticaria
To Compare Efficacy and Safety of CT-P39 and EU-approved Xolair in Patients With Chronic Spontaneous Urticaria
리드: 셀트리온
상세 →NCT04426890
1상완료· Healthy Male Subjects
A Phase I Study to Evaluate the Safety and Pharmacokinetics of CT-P41 and EU-approved Prolia in Healthy Male Subjects
리드: 셀트리온
상세 →NCT04512872
2/3상완료· SARS-CoV-2 Infection
A Phase 2/3 Study to Evaluate the Efficacy and Safety of CT-P59 in Patients With Mild to Moderate SARS-CoV-2 Infection
리드: 셀트리온
상세 →NCT04602000
1상완료· SARS-CoV-2 Infection
This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19)
리드: 셀트리온
상세 →NCT04593641
3상완료· Ulcerative Colitis
CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Ulcerative Colitis (LIBERTY-UC)
리드: 셀트리온
상세 →NCT04205643
1상완료· Healthy Subjects
Study to Compare PK and Safety of Subcutaneous Injection of Ustekinumab and CT-P43 in Healthy Subjects
리드: 셀트리온
상세 →NCT04428814
1상완료· SARS-CoV-2 Infection
To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P59 in Healthy Subjects
리드: 셀트리온
상세 →NCT04525079
1상완료· Healthy
To Compare the PK and Safety of Omalizumab (CT-P39, EU-approved Xolair, and US-licensed Xolair) in Healthy Subjects
리드: 셀트리온
상세 →NCT04018313
4상완료· Diabetes Mellitus, Type 2
A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by DPP-4 Inhibitor and Metformin Therapy
리드: 셀트리온
상세 →NCT03499704
3상완료· Crohn's Disease
CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Crohn's Disease (LIBERTY-CD)
리드: 셀트리온
상세 →NCT03945019
단계 미표기완료· Essential Hypertension
A Study for PMS of AZL-M/CLD FDC in the Treatment of Participants With Essential HTN in South Korea
리드: 셀트리온
상세 →NCT04470830
3상완료· Rheumatoid Arthritis
A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis
리드: 셀트리온
상세 →NCT04171414
1상완료· Healthy
To Compare the Pharmacokinetics and Safety of the Auto-injector and Pre-filled Syringe of CT-P17
리드: 셀트리온
상세 →NCT04295356
1상완료· Healthy
To Compare the Pharmacokinetics and Safety of CT-P17 and Humira in Healthy Subjects
리드: 셀트리온
상세 →NCT03970824
1상완료· Healthy
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 or CT-G11 and Food Effect of CT-G20 in Human Participants
리드: 셀트리온
상세 →NCT03918967
3상완료· Adenocarcinoma of Lung
To Compare Efficacy and Safety of CT-P16 and European Union-Approved Avastin as First-Line Treatment for Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer
리드: 셀트리온
상세 →NCT03676192
3상완료· Rheumatoid Arthritis
A Study to Compare Efficacy and Safety of CT-P17 With Humira in Patients With Active Rheumatoid Arthritis
리드: 셀트리온
상세 →NCT03789292
3상완료· Rheumatoid Arthritis
To Compare the Efficacy, Pharmacokinetics and Safety Between CT-P13 and China Approved Remicade When Co-administered With Methotrexate in Patients With Active Rheumatoid Arthritis
리드: 셀트리온
상세 →NCT03707535
단계 미표기완료· Essential Hypertension
A Study for PMS of AZL-M in the Treatment of Adult Participants With Essential Hypertension in South Korea
리드: 셀트리온
상세 →NCT04470817
1상완료· Health, Subjective
CT-P13 (Infliximab) Subcutaneous Administration by Pre-filled Syringe and Auto-injector in Healthy Subjects
리드: 셀트리온
상세 →NCT03446976
1상완료· Healthy
To Demonstrate Similarity of Pharmacokinetics and Evaluate Safety of CT-P16, EU-Approved Avastin and US-licensed Avastin
리드: 셀트리온
상세 →NCT03247673
1상완료· Crohn's Disease
A Phase I Study to Evaluate Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous in Patients With Active Crohn's Disease and Ulcerative Colitis
리드: 셀트리온
상세 →NCT02883452
3상완료· Rheumatoid Arthritis
A Phase I/III Study to Evaluate Efficacy, PK and Safety Between CT-P13 SC and CT-P13 IV in Patients With Active RA
리드: 셀트리온
상세 →NCT03147248
1상완료· Healthy Volunteers
Study Comparing Pharmacokinetics, Safety and Immunogenicity of CT-P6 and US-licensed Herceptin
리드: 셀트리온
상세 →NCT02665637
3상완료· Follicular Lymphoma
To Compare Efficacy and Safety Between CT-P10 and Rituxan in Patients With Low Tumour Burden Follicular Lymphoma
리드: 셀트리온
상세 →NCT02260804
3상완료· Crohn's Disease
Demonstrate Noninferiority in Efficacy and to Assess Safety of CT-P13 in Patients With Active Crohn's Disease
리드: 셀트리온
상세 →NCT02096861
3상완료· Rheumatoid Arthritis
PK Similarity Prospective Phase 3 Study in Patients With Rheumatoid Arthritis
리드: 셀트리온
상세 →NCT02149121
3상완료· Lymphoma, Follicular
To Demonstrate Equivalence of Pharmacokinetics and Noninferiority of Efficacy for CT-P10 in Comparison With Rituxan
리드: 셀트리온
상세 →NCT02162771
3상완료· HER2-positive Carcinoma of Breast
Efficacy and Safety Evaluating Study of CT-P6 in Her2 Positive Early Breast Cancer
리드: 셀트리온
상세 →NCT02162667
2상완료· Influenza A
A Study to Evaluate the Efficacy and Safety of CT-P27 in an Influenza Challenge Model
리드: 셀트리온
상세 →NCT02071914
1상완료· Rheumatoid Arthritis
Long-Term Efficacy and Safety of CT-P10 in Patients With RA
리드: 셀트리온
상세 →NCT01873443
1상완료· Ankylosing Spondylitis
An Extension Study to Demonstrate the Equivalence of Long-Term Efficacy and Safety of CT-P13 in Patients With Ankylosing Spondylitis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 1.1
리드: 셀트리온
상세 →NCT01571206
3상완료· Rheumatoid Arthritis
An Extension Study to Demonstrate Long-Term Efficacy and Safety of CT-P13 When Co-administered With Methotrexate in Patient With Rheumatoid Arthritis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 3.1
리드: 셀트리온
상세 →NCT01571219
1상완료· Rheumatoid Arthritis
Demonstrate the Equivalence of CT-P10 to MabThera With Respect to the Pharmacokinetic Profile in Patients With Rheumatoid Arthritis
리드: 셀트리온
상세 →NCT01534884

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.